Elan Corp. PLC ADS (ELN) News

News for Elan Corp. PLC ADS (ELN)

Sector News | Topic News

After Hours: $ 13.20

0.03 (+0.23%)

Volume: 6.1 k

7:44 PM EST Feb 9, 2012

Wed, Feb 08, 2012

2:00 AM

Elan Reports Fourth Quarter and Full-Year 2011 Financial Results - Business Wire

Wed, Feb 01, 2012

4:30 PM

Elan to Present at the Leerink Swann 2012 Global Healthcare Conference - Business Wire

Thu, Jan 26, 2012

8:00 AM

ASCEND Study to Evaluate the Effectiveness of TYSABRI® (natalizumab) as a Treatment for Secondary-Progressive Multiple Sclerosis - Business Wire

Wed, Jan 25, 2012

4:30 PM

Elan Announces Webcast of Fourth Quarter and Full-Year 2011 Financial Results - Business Wire

Fri, Jan 20, 2012

4:40 PM

FDA Updates TYSABRI® (natalizumab) Label to Include Anti-JC Virus Antibody Status as a PML Risk Factor - Business Wire

4:40 PM

FDA Updates TYSABRI® (natalizumab) Label to Include Anti-JC Virus Antibody Status as a PML Risk Factor - Business Wire

4:00 PM

Quest Diagnostics STRATIFY JCV(tm) First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients - PR Newswire

Tue, Jan 17, 2012

9:00 AM

A Forward Look, the Year Ahead - Featured Research on Elan Corporation, plc (ADR) and Biogen Idec Inc. - Marketwire

Mon, Dec 12, 2011

2:00 AM

University College Dublin and Elan Announce Initiative to Create Leadership in Biotechnology - Business Wire

Tue, Nov 29, 2011

5:30 PM

Elan Provides an Update on ELND005 (Scyllo-inositol) - Business Wire

Mon, Nov 28, 2011

2:00 AM

Cambridge-Elan Centre for Research Innovation and Drug Discovery Launched - Business Wire

Wed, Nov 02, 2011

8:15 AM

Equity Research on Elan Corp. plc and Hospira Inc. - Fortunes Change Quickly in Drug Delivery - Marketwire

Mon, Aug 22, 2011

9:55 AM

The Zacks Analyst Blog Highlights: Par Pharmaceutical Companies, Intellipharmaceutics International, Celgene Corporation, Novartis AG and Elan Corporation plc - PR Newswire

Tue, Aug 02, 2011

8:53 AM

Analytical Reports on Valeant Pharmaceuticals International and Elan Corp. plc - High Volatility Seen in Many Drug Delivery Companies - Marketwire

Fri, Jun 10, 2011

9:00 AM

Enhance or Disrupt? Report on Healthcare Reform -- Equity Research on Elan Corporation and Biogen Idec Inc. - Marketwire

Wed, Jun 01, 2011

8:53 AM

Equity Research on Elan Corp. plc and Valeant Pharmaceuticals International - M&A in Drug Delivery Sector - Marketwire

Fri, Mar 11, 2011

8:32 AM

Equity Research on Elan Corp. plc and Valeant Pharmaceuticals International - Drug Delivery Sector Sees Opportunities and Growing Sales - Marketwire

Wed, Mar 02, 2011

5:34 PM

Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Elan Corporation, PLC to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the April 26, 2011 Lead Plaintiff Deadline - Marketwire

Thu, Feb 04, 2010

12:46 PM

Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research - Canada Newswire

Fri, Dec 21, 2007

4:15 PM

Elan and Transition Therapeutics Dose First Patient in Phase 2 Clinical Study of ELND005 (AZD-103) in Alzheimer's Disease - Canada Newswire

Mon, Jun 05, 2006

1:35 PM

FDA Approves the Reintroduction of TYSABRI(R) for the Treatment of Relapsing Forms of Multiple Sclerosis - Canada Newswire